ID
28563
Description
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology
Keywords
Versions (2)
- 12/18/17 12/18/17 -
- 1/22/18 1/22/18 -
Copyright Holder
Prof. Dr. Dr. h.c. Thomas Luger
Uploaded on
January 22, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Visit 7 Psoriasis NCT02695940
Visit 7 Psoriasis NCT02695940
- StudyEvent: ODM
Description
I. Medical history und körperliche Untersuchung
Description
adverse events
Data type
text
Alias
- UMLS CUI [1]
- C0877248
Description
change concomitant medication
Data type
text
Alias
- UMLS CUI [1]
- C2347852
Description
Adverse event causality
Data type
text
Alias
- UMLS CUI [1]
- C2985911
Description
Unterschrift
Similar models
Visit 7 Psoriasis NCT02695940
- StudyEvent: ODM